Story Poster
Video Tour
Kyle Field Discussion
Texas A&M Football

Post-Phase I Kyle Field revealed to media

September 4, 2014
43,322
Speakers on the Kyle Field tour:
  • Philip Ray, Chief Business Development Officer
  • Dr. Tim Lomax, Texas A&M Transportation Institute
  • Todd Christner, IBM

Discussion from...

Post-Phase I Kyle Field revealed to media

29,447 Views | 7 Replies | Last: 10 yr ago by TexAgs91
TexAgs Studios
User Profile
Private Message
How long do you want to ignore this user?
24 hours One week Permanently Cancel
8:18p, 9/4/14
Staff
Post-Phase I Kyle Field revealed to media
Reply Quote
ABATTBQ11
User Profile Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
9:04a, 9/5/14
AG
Wow...
Reply Quote
Matsui
User Profile Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
9:46a, 9/5/14
AG
OMG - AMAZING
Reply Quote
BaileyAg
User Profile Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
10:05a, 9/5/14
Bunny Ag
User Profile Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
10:08a, 9/5/14
need more lipstick on that pig
Reply Quote
GCRanger
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
10:00p, 9/5/14
AG
The technology being put in is fascinating. I wish I could be there tomorrow to watch the game on my phone.
Reply Quote
ProudAg16
User Profile Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
9:47a, 9/6/14
AG
Awesome!
Reply Quote
TexAgs91
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
9:49a, 9/6/14
AG
Lesbians at 1:21 on Kyle Field Discussion
Reply Quote
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.